IRIS
DI NISIO, Marcello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.272
AS - Asia 5.531
EU - Europa 4.711
SA - Sud America 875
Continente sconosciuto - Info sul continente non disponibili 756
AF - Africa 125
OC - Oceania 12
Totale 23.282
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.892
SG - Singapore 2.492
CN - Cina 1.375
IE - Irlanda 771
RU - Federazione Russa 707
BR - Brasile 695
IT - Italia 684
UA - Ucraina 626
VN - Vietnam 546
SE - Svezia 532
TR - Turchia 424
GB - Regno Unito 418
DE - Germania 306
FR - Francia 213
FI - Finlandia 176
CA - Canada 167
IN - India 144
HK - Hong Kong 124
BD - Bangladesh 81
AR - Argentina 70
MX - Messico 60
AT - Austria 47
ES - Italia 46
NL - Olanda 44
PL - Polonia 43
JP - Giappone 39
CO - Colombia 35
IQ - Iraq 34
ID - Indonesia 33
IL - Israele 32
ZA - Sudafrica 30
EC - Ecuador 28
JM - Giamaica 26
BE - Belgio 25
SC - Seychelles 23
TW - Taiwan 23
CR - Costa Rica 21
PK - Pakistan 21
HN - Honduras 20
PH - Filippine 19
CZ - Repubblica Ceca 15
GT - Guatemala 15
SA - Arabia Saudita 15
VE - Venezuela 15
KR - Corea 14
JO - Giordania 13
LT - Lituania 13
MA - Marocco 13
EU - Europa 12
UZ - Uzbekistan 12
AU - Australia 11
EG - Egitto 11
KE - Kenya 11
MY - Malesia 11
NI - Nicaragua 11
EE - Estonia 10
SV - El Salvador 10
TT - Trinidad e Tobago 10
PY - Paraguay 9
TN - Tunisia 9
DO - Repubblica Dominicana 8
GP - Guadalupe 8
PR - Porto Rico 8
TH - Thailandia 8
AZ - Azerbaigian 7
IR - Iran 7
PS - Palestinian Territory 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
KZ - Kazakistan 6
PE - Perù 6
RO - Romania 6
CW - ???statistics.table.value.countryCode.CW??? 5
ET - Etiopia 5
LB - Libano 5
QA - Qatar 5
UY - Uruguay 5
DK - Danimarca 4
DZ - Algeria 4
KG - Kirghizistan 4
OM - Oman 4
AL - Albania 3
AM - Armenia 3
BB - Barbados 3
BH - Bahrain 3
BO - Bolivia 3
CG - Congo 3
CH - Svizzera 3
GA - Gabon 3
HR - Croazia 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
SR - Suriname 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
GR - Grecia 2
HT - Haiti 2
HU - Ungheria 2
Totale 22.507
Salva come PNG Salva come JPEG
Città #
Singapore 1.767
San Jose 1.093
Chandler 995
Jacksonville 862
Dublin 760
Ashburn 683
Dallas 413
Princeton 390
Council Bluffs 379
Beijing 328
Izmir 270
Santa Clara 250
Los Angeles 242
Nanjing 215
Ho Chi Minh City 200
Altamura 184
Southend 177
Wilmington 170
North Bergen 161
Cambridge 137
Dearborn 132
Buffalo 127
The Dalles 118
Hong Kong 113
Hanoi 107
New York 96
Houston 95
Boardman 94
Ann Arbor 83
São Paulo 76
Tongling 75
Nanchang 70
Woodbridge 69
Helsinki 62
Chieti 61
Redondo Beach 61
Phoenix 59
Moscow 53
Atlanta 51
Kunming 47
Munich 47
Orem 47
Brooklyn 46
Hebei 45
Chicago 43
Seattle 43
Montreal 42
Milan 40
Washington 40
Shenyang 36
Tianjin 36
Warsaw 36
Tokyo 35
Jiaxing 34
Mount Pleasant 34
Rome 33
Denver 31
Dong Ket 31
Vienna 29
Hefei 28
Nuremberg 28
Columbus 27
Kimball 27
San Francisco 27
Haiphong 26
Pescara 26
Toronto 26
Changsha 25
Frankfurt am Main 25
London 25
Norwalk 25
Chennai 24
Kyle 24
Poplar 24
St Louis 24
Brussels 22
Manchester 22
Amsterdam 20
Boston 20
Philadelphia 20
Baghdad 19
Da Nang 19
Guangzhou 19
Johannesburg 19
Mexico City 19
Rio de Janeiro 19
Brasília 18
Hangzhou 18
League City 18
Cleveland 17
Shanghai 17
San Antonio 16
Stockholm 16
Naples 15
Fairfield 14
Kingston 14
Pune 14
Amman 13
Biên Hòa 13
Falls Church 13
Totale 12.898
Salva come PNG Salva come JPEG
Nome #
Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation 385
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study 251
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer 239
Medication review interventions to reduce hospital readmissions in older people 229
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 184
Supportive management strategies for disseminated intravascular coagulation: An international consensus 183
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 180
Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study 178
24 weeks of Pilates-aerobic and educative training to improve body fat mass in elderly Serbian women 170
Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis 157
Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation 156
A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC 153
Circulating leptin is associated with oxidized LDL in postmenopausal women. 146
Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review 146
Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants 146
Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese patients. 144
Treatment of Lower Extremity Superficial Thrombophlebitis 144
Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization 144
Non-O blood group and outcomes of in vitro fertilization 143
Acute complications and mortality in hospitalized patients with coronavirus disease 2019: A systematic review and meta-analysis 143
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis 142
Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation 142
Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease 141
ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer 140
Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation 140
Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. 137
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. 137
Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis 137
Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness 136
Deep vein thrombosis and pulmonary embolism 135
Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity 135
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 135
Dementia in patients with atrial fibrillation and the value of the Hachinski ischemic score 134
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study 131
A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients 131
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia 131
Residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer 131
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 130
Anticoagulant treatment of cancer patients with pulmonary embolism in the real world: Actual use of low-molecular-weight heparin in cancer 129
Edoxaban for the treatment of cancer-associated venous thromboembolism 129
Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: A systematic review and meta-analysis 129
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis 128
Identification of three genetic risk factors for venous thrombosis using a multiplex allele-specific PCR assay: comparison of conventional and new alternative methods for the preparation of DNA from clinical samples 127
Low-molecular-weight heparin for the treatment of acute venous thromboembolism in patients with active cancer 127
Computerised cognitive training for preventing dementia in people with mild cognitive impairment 127
Association of Factor VII Levels With Inflammatory Parameters in Hypercholesterolemic Patients. 126
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19 126
Safety and efficacy of low-dose fondaparinux (1.5mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: The FONDAIR study 125
Effects of body composition on the procoagulant imbalance in obese patients 125
Edoxaban for treatment of venous thromboembolism in patients with cancer: Rationale and design of the hokusai VTE-cancer study 124
Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta-analysis 123
Use of heparins in patients with cancer: Individual participant data metaanalysis of randomised trials study protocol 122
Whole-Arm ultrasound for suspected upper-extremity deep venous thrombosis in outpatients 121
Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone 121
Rivaroxaban for cancer-associated cardiac thrombosis 120
Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis 120
Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH 119
Antithrombotic treatment for retinal vein occlusion: a systematic review and meta-analysis 118
Improving the diagnostic management of upper extremity deep vein thrombosis 118
Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis 118
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 117
The diagnostic management of upper extremity deep vein thrombosis: A review of the literature 117
Anticoagulant treatment for upper extremity deep vein thrombosis: A systematic review and meta-analysis 117
Increased phosphatidylserine exposure on platelets from hospitalized patients with acute medical illnesses 116
Cannabinoids for medical use: A systematic review and meta-analysis 116
Antithrombotic therapy and cancer 115
Treatment of venous thromboembolism with rivaroxaban in relation to body weight: A sub-analysis of the EINSTEIN DVT/PE studies 115
A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism 115
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in late life 115
Frailty phenotype as a predictor of bleeding and mortality in ambulatory patients receiving direct oral anticoagulants 114
The hematocrit and platelet target in polycytemia vera 114
Trasforming growth factor-beta 1 levels in hypertensive patients: association with body mass index and leptin. 114
Management of venous thromboembolism in cancer patients: Considerations about the clinical practice guideline update of the American society of clinical oncology 114
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts 114
Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients 114
Treatment with tirofiban for acute coronary syndrome (ACS): a systematic review and network analysis 113
Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life 113
Cancer-associated unsuspected pulmonary embolism 113
Relationship between type of unprovoked venous thromboembolism and cancer location: An individual patient data meta-analysis 113
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife 113
D-Dimer test in cancer patients with suspected acute pulmonary embolism 113
Long-term clinical outcomes of splanchnic vein thrombosis results of an international registry 113
NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis 111
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists 111
D-Dimer Test In Cancer Patients With Suspected Acute Pulmonary Embolism 111
Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study 111
Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET) 111
High-dose versus low-dose venous thromboprophylaxis in hospitalized patients with COVID-19: a systematic review and meta-analysis 110
Treatment for superficial infusion thrombophlebitis of the upper extremity. 110
Incidental pulmonary embolism in cancer patients: Interobserver agreement on the diagnosis and extent with a focus on distal clots 108
Splanchnic vein thrombosis: Current perspectives 108
Effects of Obesity and Thrombophilia on the Risk of Abortion in Women Undergoing In Vitro Fertilization 108
Antithrombotic therapy for venous thromboembolism in patients with cancer: expert guidance 107
Prognostic nutritional index in elderly patients hospitalized for acute heart failure 107
Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis 106
Combined use of clinical pretest probability and D-dimer test in cancer patients with clinically suspected deep venous thrombosis 106
The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis 106
Underlying disorders of disseminated intravascular coagulation: Communication from the ISTH SSC Subcommittees on Disseminated Intravascular Coagulation and Perioperative and Critical Care Thrombosis and Hemostasis 106
The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants 106
Transforming growth factor-β1 levels in hypertensive patients: association with body mass index and leptin 106
Totale 13.255
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.389
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022610 0 0 0 0 34 27 31 65 53 22 107 271
2022/20232.936 248 386 132 306 326 583 155 223 380 42 95 60
2023/20241.281 98 45 140 48 106 370 254 49 27 39 5 100
2024/20252.979 200 619 401 62 52 97 76 250 344 130 344 404
2025/20266.965 502 270 769 847 715 401 1.123 483 804 665 299 87
2026/20273.660 413 705 520 1.478 544 0 0 0 0 0 0 0
Totale 23.282